Golidocitinib Combined With GemOx in RR PTCL

Clinical trial NCT07279584 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07279584
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphomas (PTCL)

Start date: 2025-12-20
Primary completion: 2026-12-31
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.